Taiwan accuses China of interfering with Covid vaccine deals

President says agreement with German firm BioNTech has been delayed after Beijing intervention

Taiwan’s president has accused China of interfering in its vaccine acquisition programme, as the island continues to battle hundreds of daily new cases of Covid-19 with low supplies of vaccines.

Taiwan has received about 700,000 doses of the AstraZeneca vaccine so far, for a population of 24 million. While the island had been largely Covid-free since the pandemic began, an outbreak in late April has so far infected more than 5,000 people, and killed at least 47. Less than 2% of the population are vaccinated.

The president, Tsai Ing-wen, said Taiwan had made successful deals with AstraZeneca from the UK and Moderna from the US, and was engaging with Germany’s BioNTech for the Pfizer vaccine.

“We had almost completed the contract signing with the German manufacturer at one point, but it has been delayed till now because China has interfered,” Tsai told a party meeting on Wednesday, in the most explicit comments to date, after months of suggestions that Beijing had been getting in the way of Taiwan’s procurement process.

Pfizer/BioNTech reportedly has an exclusive deal with the Shanghai-based pharmaceuticals company Fosun to distribute the vaccine to the Greater China region, including Hong Kong, Macau and Taiwan. Fosun has offered to supply Taiwan with vaccine doses, but Taiwan has said it is not possible.

In her Facebook post, Tsai laid out three principles for Taiwan’s vaccine procurement, one of which was that it would only deal with the direct manufacturers to ensure quality control.

In August, the health and welfare minister, Chen Shih-shung, said Taiwan had a longstanding policy against buying Chinese-made vaccines and other biological products. Taiwanese law allows the government to exempt some Chinese products from import bans, as long as they do not endanger national security or negatively impact related domestic industries.

On Thursday Chen gave some details of the deal’s collapse. He said Taiwan returned a signed contract to BioNTech in January, followed by a draft press release which BioNTech approved but then hours later asked to remove a reference where Taiwan called itself a country. One week later BioNTech said there were supply chain issues and needed time to make amendments.

BioNTech has been contacted for comment.

Beijing denies obstructing Taiwan’s deal with BioNtech and has accused Taiwan’s leaders of sacrificing the health of residents for politics. Taiwan’s opposition Kuomintang party has accused Tsai of bungling the vaccine rollout.

“Taiwan access to vaccines continues to be slowed down by Chinese interference, while they insist we buy Chinese-made ones,” said Taiwan’s presidential spokesperson, Kolas Yotaka. “If you really want to help, please don’t stand in the doorway, don’t block up the hall.”

The need for vaccines in Taiwan, an island democracy claimed by Beijing as part of its territory, has become more urgent with its recent outbreak. The second batch of AstraZeneca vaccines – totalling 410,000 doses – were cleared for distribution on Thursday.

On Facebook, Tsai said Taiwan had purchased 30m doses – enough to fully vaccinate about 60% of the population – with 10m expected to be delivered by August. According to reports, this number includes domestically produced vaccines currently in trial stage.

“We will do everything to safeguard a speedy delivery and offer more vaccines for anyone who wants a jab. The process for domestic-made vaccines is up and running and will provide us sufficient doses,” she said.

“For all the Taiwanese, and all the mayors and county [leaders], I realise everyone is concerned about the progress of the vaccine, especially when the situation seems intimidating. So I am asking everybody to support CECC [Central Epidemic Command Center] on vaccine acquisition.”

Taiwan has also been in talks with the US, seeking guarantees for some of the 20m doses Joe Biden has said will be sent overseas by July. But in farewell remarks on Wednesday, the US’s representative in Taiwan, Brent Christensen, suggested Taiwan’s impressive Covid management and relatively low case numbers meant it would not be prioritised over other harder-hit places.


Helen Davidson in Taipei

The GuardianTramp

Related Content

Article image
Thailand starts Covid vaccine drive using jabs made by king’s firm
Country aims to vaccinate 70% of people this year but experts express doubts amid supply concerns

Rebecca Ratcliffe in Bangkok

07, Jun, 2021 @3:14 PM

Article image
Revealed: big shortfall in Covax Covid vaccine-sharing scheme
Only a fifth of Oxford/AstraZeneca doses expected by May delivered as export bans, hoarding and supply shortages bite

Michael Safi and Ashley Kirk

22, Apr, 2021 @9:35 AM

Article image
Taiwan tech companies buy 10m Covid vaccine doses in deal that sidesteps China
Beijing had offered vaccines amid a major shortage on island, but Taipei did not want to deal with China directly

Helen Davidson in Taipei

12, Jul, 2021 @7:58 AM

Article image
China approves Sinopharm Covid-19 vaccine for general use
Rollout to begin ‘soon’ but about a million have already received injection under emergency approvals

Helen Davidson in Taipei

31, Dec, 2020 @3:52 AM

Article image
Homegrown Covid vaccines fill gap as UN Covax scheme misses target
India, Egypt and Brazil among countries developing and making their own vaccines after Covax falls behind

Hazem Badr, Helen Mendes and Papiya Bhattacharya

13, Oct, 2021 @6:00 AM

Article image
Oxford University Covid-19 vaccine firm says it is not in talks with Trump
AstraZeneca insists it has not discussed ‘emergency use authorisation’ with the US

Peter Beaumont and Sarah Boseley

24, Aug, 2020 @12:28 PM

Article image
Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief
Pharmaceutical firm’s boss says 2020 deadline possible if regulators move fast

Julia Kollewe

10, Sep, 2020 @9:15 AM

Article image
Covid vaccines: India export delay deals blow to poorer countries
Efforts in Africa and elsewhere hit by decision not to export AstraZeneca jab until end of year

Jason Burke in Johannesburg, Patrick Wintour and Rebecca Ratcliffe, south-east Asia correspondent

19, May, 2021 @12:18 PM

Article image
Japan’s Moderna Covid vaccine rollout hit by recall and contamination scares
Foreign materials including stainless steel identified in batches of Covid-19 vaccine in the country though no safety or efficacy issues reported

Gavin Blair in Tokyo

02, Sep, 2021 @5:20 AM

Article image
France and Germany threaten AstraZeneca over vaccine shortage
Warning of ‘legal commitment’ and concern that doses might have been diverted from the EU to the UK

Daniel Boffey in Brussels

31, Jan, 2021 @12:20 PM